{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-135890","form_type":"8-K","ticker":"APVO","cik":"0001671584","company_name":"Aptevo Therapeutics Inc.","filed_at":"2024-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.178186+00:00","generated_at":"2026-05-29T04:08:25.718942+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aptevo raises up to $6.2M via warrant exercise inducement; issues new warrants at $9.53","bullets":["Holders exercise up to 823,544 existing warrants at $7.50/share for ~$6.2M gross proceeds.","Company issues new warrants to buy 200% of shares exercised at $9.53, 5-year term.","Roth Capital gets 7% advisory fee; proceeds used for working capital.","Resale registration statement for new warrant shares due by Dec. 27, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-135890","json":"https://secwatch.observer/filing/0000950170-24-135890.json","markdown":"https://secwatch.observer/filing/0000950170-24-135890.md","text":"https://secwatch.observer/filing/0000950170-24-135890.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024135890/0000950170-24-135890-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024135890/apvo-20241212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:08:25.718942+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}